120 related articles for article (PubMed ID: 17876089)
1. Isolation, expansion, and characterization of human natural and adaptive regulatory T cells.
Gregori S; Bacchetta R; Passerini L; Levings MK; Roncarolo MG
Methods Mol Biol; 2007; 380():83-105. PubMed ID: 17876089
[TBL] [Abstract][Full Text] [Related]
2. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
4. Thymic regulatory T cells.
Maggi E; Cosmi L; Liotta F; Romagnani P; Romagnani S; Annunziato F
Autoimmun Rev; 2005 Nov; 4(8):579-86. PubMed ID: 16214099
[TBL] [Abstract][Full Text] [Related]
5. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
6. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
7. Isolation, propagation and characterization of cord blood derived CD4+ CD25+ regulatory T cells.
Bresatz S; Sadlon T; Millard D; Zola H; Barry SC
J Immunol Methods; 2007 Oct; 327(1-2):53-62. PubMed ID: 17804010
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
Crellin NK; Garcia RV; Levings MK
J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
[TBL] [Abstract][Full Text] [Related]
9. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
10. Methods for in vitro generation of human type 1 regulatory T cells.
Gregori S; Roncarolo MG; Bacchetta R
Methods Mol Biol; 2011; 677():31-46. PubMed ID: 20941601
[TBL] [Abstract][Full Text] [Related]
11. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
Roncarolo MG; Gregori S; Levings M
Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
[TBL] [Abstract][Full Text] [Related]
12. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
[TBL] [Abstract][Full Text] [Related]
13. Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation.
Berglund D; Korsgren O; Lorant T; Schneider K; Tufveson G; Carlsson B
Transpl Immunol; 2012 Jan; 26(1):27-33. PubMed ID: 21958749
[TBL] [Abstract][Full Text] [Related]
14. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
Cong Y; Wang L; Konrad A; Schoeb T; Elson CO
Eur J Immunol; 2009 Nov; 39(11):3134-46. PubMed ID: 19839007
[TBL] [Abstract][Full Text] [Related]
16. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
17. Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3.
Veldman C; Pahl A; Hertl M
Immunology; 2009 May; 127(1):40-9. PubMed ID: 18800988
[TBL] [Abstract][Full Text] [Related]
18. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
[TBL] [Abstract][Full Text] [Related]
19. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.
Nakamura S; Suzuki M; Sugimoto A; Tsuji-Takayama K; Yamamoto M; Otani T; Inoue T; Harashima A; Okochi A; Motoda R; Yamasaki F; Orita K; Kibata M
Exp Hematol; 2007 Feb; 35(2):287-96. PubMed ID: 17258077
[TBL] [Abstract][Full Text] [Related]
20. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Parietti V; Monneaux F; Décossas M; Muller S
Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
